
Please try another search
TAO Synergies Inc. owns and operates an AI token. The company executes a cryptocurrency treasury strategy centered on the acquisition and staking of the TAO token, the native utility token of the Bittensor network. TAO Synergies Inc. was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. The company was incorporated in 2012 and is headquartered in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
George Perry | 68 | 2017 | Chairman of the Scientific Advisory Board |
Bruce T. Bernstein | 58 | 2016 | Independent Director |
Jonathan L. Schechter | 50 | 2018 | Independent Director |
Marwan Noel Sabbagh | 58 | - | Member of Scientific Advisory Board |
Robert Howard | - | - | Member of Scientific Advisory Board |
Paul Coleman | - | - | Member of Scientific Advisory Board |
Zaven Khachaturian | - | - | Member of Scientific Advisory Board |
William S. Singer | 84 | 2019 | Independent Vice-Chairman of the Board |
Alan J. Tuchman | 78 | 2020 | Chief Medical Officer & Director |
Joshua N. Silverman | 55 | 2016 | Executive Chairman of the Board |
Daniel L. Alkon | 83 | 2016 | President & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review